Mixed-mode versus paper surveys for patient-reported outcomes after critical illness: A randomised controlled trial

被引:0
|
作者
Wong, Hao Z. [1 ]
Brusseleers, Maarten [2 ]
Hall, Kelly A. [3 ]
Maiden, Matthew J. [1 ,4 ,5 ]
Chapple, Lee-anne S. [1 ,5 ]
Chapman, Marianne J. [1 ,5 ]
Hodgson, Carol L. [6 ,7 ]
Gluck, Samuel [1 ,5 ]
机构
[1] Royal Adelaide Hosp, Intens Care Unit, 1 Port Rd, Adelaide, SA 5000, Australia
[2] Ziekenhuis Oost Limburg, Intens Care & Anaesthesia, Genk, Belgium
[3] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia
[4] Barwon Hlth, Intens Care Unit, Geelong, Vic, Australia
[5] Univ Adelaide, Sch Acute Care Med, Adelaide, SA, Australia
[6] Monash Univ, Australia & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia
[7] Alfred Hosp, Dept Physiotherapy, Melbourne, Vic, Australia
关键词
Critical care; Electronic mail; Mental disorders; Patient-reported outcome measures; Quality of life; Surveys and questionnaires; POSTTRAUMATIC-STRESS-DISORDER; RESPONSE RATES; SURVIVORS; IMPACT; IMPLEMENTATION; DEPRESSION; TELEPHONE; INTERNET; ANXIETY; MAIL;
D O I
10.1016/j.aucc.2021.04.006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The aim of the study was to determine the response rate to a mixed-mode survey using email compared with that to a paper survey in survivors of critical illness. Design: This is a prospective randomised controlled trial. Setting: The study was conducted at a single-centre quaternary intensive care unit (ICU) in Adelaide, Participants: Study participants were patients admitted to the ICU for >48 h and discharged from the hospital. Interventions: The participants were randomised to receive a survey by paper (via mail) or via online (via email, or if a non-email user, via a letter with a website address). Patients who did not respond to the initial survey received a reminder paper survey after 14 days. The survey included quality of life (EuroQol-5D-5L), anxiety and depression (Hospital Anxiety and Depression Scale), and post-traumatic symptom (Impact of Event Scale-Revised) assessment. Main outcome measures: Survey response rate, extent of survey completion, clinical outcomes at different time points after discharge, and survey cost analysis were the main outcome measures. Outcomes were stratified based on follow-up time after ICU discharge (3, 6, and 12 months). Results: A total of 239 patients were randomised. The response rate was similar between the groups (mixed-mode: 78% [92/118 patients] vs. paper: 80% [97/121 patients], p 1/4 0.751) and did not differ between time points of follow-up. Incomplete surveys were more prevalent in the paper group (10% vs 18%). The median EuroQol-5D-5L index value was 0.83 [0.71-0.92]. Depressive symptoms were reported by 25% of patients (46/187), anxiety symptoms were reported by 27% (50/187), and probable posttraumatic stress disorder was reported by 14% (25/184). Patient outcomes did not differ between the groups or time points of follow-up. The cost per reply was AU$ 16.60 (mixed-mode) vs AU$ 19.78 (paper). Conclusion: The response rate of a mixed-mode survey is similar to that of a paper survey and may provide modest cost savings. Crown Copyright (c) 2021 Published by Elsevier Ltd on behalf of Australian College of Critical Care Nurses Ltd. All rights reserved.
引用
收藏
页码:286 / 293
页数:8
相关论文
共 50 条
  • [1] Effect of mode of delivery of patient reported outcomes in patients with breast disease: a randomised controlled trial
    Pantiora, Eirini
    Hedman, Lia-Chasmine
    Aristokleous, Iliana
    Sjokvist, Olivia
    Karakatsanis, Andreas
    Schiza, Aglaia
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (01) : 176 - 182
  • [2] Effect of detection of need for care on lung cancer patient-reported outcomes: A randomised controlled trial.
    Geerse, Olaf P.
    Hoekstra-Weebers, Josette E. H. M.
    Stokroos, Marleen H.
    Groen, Harry J. M.
    Kerstjens, Huib A. M.
    Hiltermann, Thijo Jeroen Nicolaas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] A randomised, controlled trial of the effects of a mobile telehealth intervention on clinical and patient-reported outcomes in people with poorly controlled diabetes
    Baron, Justine S.
    Hirani, Shashivadan
    Newman, Stanton P.
    [J]. JOURNAL OF TELEMEDICINE AND TELECARE, 2017, 23 (02) : 207 - 216
  • [4] Study within a trial of electronic versus paper-based Patient-Reported oUtcomes CollEction (SPRUCE): study protocol for a partially randomised patient preference study
    Philipps, Lara
    Foster, Stephanie
    Gardiner, Deborah
    Gath, Jacqui
    Gillman, Alexa
    Haviland, Joanne
    Hill, Elizabeth
    King, Diana
    Manning, Georgina
    Stiles, Morgaine
    Hall, Emma
    Lewis, Rebecca
    [J]. BMJ OPEN, 2023, 13 (09):
  • [5] The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols
    Rebecca Mercieca-Bebber
    Michael Friedlander
    Peey-Sei Kok
    Melanie Calvert
    Derek Kyte
    Martin Stockler
    Madeleine T. King
    [J]. Quality of Life Research, 2016, 25 : 2457 - 2465
  • [6] The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols
    Mercieca-Bebber, Rebecca
    Friedlander, Michael
    Kok, Peey-Sei
    Calvert, Melanie
    Kyte, Derek
    Stockler, Martin
    King, Madeleine T.
    [J]. QUALITY OF LIFE RESEARCH, 2016, 25 (10) : 2457 - 2465
  • [7] Patient-reported common symptoms as an assessment of interventions in medication reviews: a randomised, controlled trial
    Schoenmakers, Tim W. A.
    Wensing, Michel
    De Smet, Peter A. G. M.
    Teichert, Martina
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 126 - 134
  • [8] Patient-reported outcomes in randomised controlled trials on age-related macular degeneration
    Krezel, Aniela K.
    Hogg, Ruth E.
    Azuara-Blanco, Augusto
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (11) : 1560 - 1564
  • [9] Patient-reported common symptoms as an assessment of interventions in medication reviews: a randomised, controlled trial
    Tim W. A. Schoenmakers
    Michel Wensing
    Peter A. G. M. De Smet
    Martina Teichert
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 126 - 134
  • [10] Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
    Strand, Vibeke
    Lee, Eun Bong
    Fleischmann, Roy
    Alten, Rieke E.
    Koncz, Tamas
    Zwillich, Samuel H.
    Gruben, David
    Wilkinson, Bethanie
    Krishnaswami, Sriram
    Wallenstein, Gene
    [J]. RMD OPEN, 2016, 2 (02):